This selectivity makes it invaluable for studies requiring lipolytic effects without the confounding variables of growth promotion, glucose alterations, or anabolic signalingallowing researchers to study fat metabolism in isolation
Key Research Areas Extracellular matrix remodelling GHK-Cu is extensively referenced in studies on collagen, elastin, and glycosaminoglycan synthesis in laboratory tissue models Wound healing mechanisms Investigated in controlled studies for its role in fibroblast activation, keratinocyte migration, and angiogenesis signalling Anti-inflammatory pathways Studied for inhibition of NF-B signalling and reduction of pro-inflammatory cytokine expression in cell culture Antioxidant activity Research has examined its capacity to upregulate superoxide dismutase and other endogenous antioxidant enzymes Nerve and tissue regeneration Referenced in studies exploring nerve growth factor (NGF) expression and axonal regeneration in vitro Hair follicle biology Investigated for effects on dermal papilla cell proliferation and follicle stimulation in skin research models Gene expression modulation Genome-wide studies have identified GHK-Cu as a potential modulator of over 4,000 human genes associated with tissue repair and inflammatory response Product Specifications About the Compound GHK-Cu is a tripeptide (Gly-His-Lys) with a high affinity for copper ions (Cu), forming a stable complex that has demonstrated significant biological activity across hundreds of peer-reviewed studies
The shipping and storage protocols used by Loti Labs are designed to maintain compound stability during transit and delivery
But some users do report mild side effects, including: Headaches or dizziness (typically at higher doses or when stacking with GH-related peptides) Injection site irritation , redness, or swelling Nausea or GI discomfort when taken orally (more common with low-quality forms) Changes in mood or energy , including restlessness or mild anxiety These symptoms are usually temporary and resolve quickly with dosage adjustment or cycling off
Subcutaneous injection into the abdomen (at least 2 inches from the navel), upper thigh, or upper arm
The "half-step" approach: Some researchers soften the 2mg to 4mg transition by doing one week at 3mg before moving to 4mg
